STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Nasdaq grants Curis (CRIS) MVLS exception; target $35,000,000

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Curis, Inc. reported that Nasdaq’s Hearings Panel granted an exception until November 14, 2025 to regain compliance with the Nasdaq Listing Rule 5550(b)(2) market value of listed securities requirement of $35,000,000.

During this period, the company must promptly notify Nasdaq of any significant events affecting compliance, and the Panel may reconsider the exception if circumstances change. The notice states there is no assurance the company will regain compliance or remain listed on Nasdaq.

Positive

  • None.

Negative

  • None.

Insights

Temporary Nasdaq compliance extension to Nov 14, 2025.

Curis has an exception from Nasdaq’s Hearings Panel through November 14, 2025 to meet the market value of listed securities threshold of $35,000,000 required by Rule 5550(b)(2). This maintains listing while the company works to satisfy the standard.

The Panel can revisit the exception if developments arise, and Curis must promptly report significant events during the period. The filing cautions there is no assurance of regaining compliance or continued listing.

Key milestone is the November 14, 2025 deadline; subsequent disclosures will clarify the outcome and any further Nasdaq actions.

0001108205false00011082052025-10-202025-10-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 

_____________________
FORM 8-K

_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event Reported): October 20, 2025
Curis, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware000-3034704-3505116
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
128 Spring Street, Building C - Suite 500, Lexington, MA 02421
(Address of Principal Executive Offices) (Zip Code)
(617) 503-6500
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:        
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.01 per shareCRIS
Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously disclosed, on August 21, 2025, Curis, Inc. (the “Company”) received notice from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not regained compliance with Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”) which requires the market value of the Company’s listed securities to be at least $35,000,000, its securities would be delisted from The Nasdaq Capital Market unless the Company timely appeals the Staff’s delisting determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”) by August 28, 2025. The Company timely requested a hearing before the Panel, which request stayed any further suspension or delisting action by the Staff, pending the ultimate conclusion of the hearing process.
On October 20, 2025, the Company received written notice from Nasdaq indicating that the Panel has granted the Company an exception until November 14, 2025 (“Exception Period”) to regain compliance with the MVLS Requirement.
During the Exception Period, the Company is required to provide prompt notification of any significant events that occur during this period that may affect the Company’s compliance with Nasdaq requirements including any event that may call into question the Company’s ability to meet the terms of the exception granted. The Panel reserves the right to reconsider the terms of this exception based on any event, condition or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of the Company’s securities on Nasdaq inadvisable or unwarranted. There can be no assurance that the Company will ultimately regain compliance and remain listed on Nasdaq.



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 Curis, Inc.
   
  
Date:October 24, 2025By: /s/ Diantha Duvall
  Diantha Duvall
  Chief Financial Officer
  

FAQ

What did Curis (CRIS) announce regarding its Nasdaq listing?

Nasdaq’s Hearings Panel granted an exception until November 14, 2025 to regain compliance with the MVLS requirement.

What MVLS threshold must Curis (CRIS) meet?

The market value of listed securities must be at least $35,000,000 under Nasdaq Listing Rule 5550(b)(2).

What conditions apply during Curis’s exception period?

Curis must promptly notify Nasdaq of any significant events affecting compliance; the Panel may reconsider the exception based on new developments.

Is Curis (CRIS) assured of remaining listed on Nasdaq?

No. The company states there is no assurance it will regain compliance or remain listed.

When does the Nasdaq exception for Curis (CRIS) expire?

The exception period runs through November 14, 2025.
Curis

NASDAQ:CRIS

CRIS Rankings

CRIS Latest News

CRIS Latest SEC Filings

CRIS Stock Data

16.68M
12.02M
7.23%
34.32%
1.23%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON